Shared on30 Jul 25Fair value Increased 43%
The notable upward revision in Claritev’s consensus price target appears driven by a significant increase in its future P/E multiple despite a modest decline in net profit margin, resulting in a new fair value estimate of $47.00. What's in the News Claritev was added to several Russell indices, including Russell 2000, 2500, 3000, Microcap, and related growth/sector benchmarks, enhancing index weighting and potential passive inflows.